You are here

  • Home
  • Archive
  • Volume 63, Issue 7
  • Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy

Article info

Article menu

This article has a correction. Please see:

Download PDFPDF
Tuberculosis
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy

Authors

  1. Dr I A Campbell, Llandough Hospital, Penarth CF64 5SD, UK; ian.campbell{at}cardiffandvale.wales.nhs.uk
View Full Text

Citation

Jenkins PA, Campbell IA, Banks J, et al
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy
Thorax 2008;63:627-634.

Publication history

  • Received July 30, 2007
  • Accepted January 9, 2008
  • First published February 4, 2008.
Online issue publication 
September 01, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2008 BMJ Publishing Group Ltd and the British Thoracic Society